[Juvenile myoclonic epilepsy: under-diagnosed syndrome]
Ksenija Bozić1, Ksenija Gebauer Bukurov, Petar Slankamenac
1Klinika za neurologiju, Kklinicki centar Vojvodine, Novi Sad. bozick@eunet.rs
Insights
Juvenile myoclonic epilepsy (JME) is a common, hereditary epilepsy syndrome often underdiagnosed. Early diagnosis and lifelong treatment with valproate are key for managing JME, which has a good prognosis.
Area of Science:
- Neurology
- Genetics
- Epileptology
Context:
- Juvenile myoclonic epilepsy (JME) is an idiopathic, hereditary epilepsy syndrome.
- Despite being a well-defined clinical entity, JME is frequently underdiagnosed.
- The exact etiology of JME remains unknown, with evidence suggesting multifactorial inheritance.
Purpose:
- To summarize the clinical manifestations, diagnosis, and management of juvenile myoclonic epilepsy.
- To highlight the importance of recognizing JME's characteristic symptoms and diagnostic criteria.
- To emphasize the need for early diagnosis and lifelong treatment for optimal patient outcomes.
Summary:
- JME presents with a triad of myoclonic jerks upon awakening, generalized tonic-clonic seizures, and occasional absences.
- Diagnosis relies on clinical presentation and characteristic electroencephalographic findings.
- Management involves lifelong monotherapy, typically with valproate, and counseling, offering a good prognosis.
Impact:
- Improved recognition and diagnosis of JME can lead to better patient management and outcomes.
- Understanding the genetic and clinical complexities of JME aids in developing more targeted therapies.
- This summary provides a concise overview for clinicians, researchers, and patients regarding JME.
Introduction:
Juvenile myoclonic epilepsy is an idiopathic, hereditary form of epilepsy. Although juvenile myoclonic epilepsy is a well defined clinical syndrome, attempts at diagnosing it commonly fail. ETIOPATHOGENESIS: The exact cause of juvenile myoclonic epilepsy remains unknown. Clinical, morphological and metabolic data suggest a preferential role for frontal regions in this syndrome. Several major genes for juvenile myoclonic epilepsy have been identified, but these genes account for only a small proportions of juvenile myoclonic epilepsy cases, suggesting multifactorial or complex inheritance in most.
Clinical Manifestations:
Juvenile myoclonic epilepsy is characterized by the triad of myoclonic jerks on awakening (all patients), generalized tonic-clonic seizures (> 90% of patients) and typical absences (about one third of patients). Seizures have an age-related onset, circadian distribution and are frequently precipitated by sleep deprivation, fatigue and alcohol intake. Intelligence is normal.
Diagnosis:
Juvenile myoclonic epilepsy diagnosis is based upon clinical criteria and typical electroencephalographic findings (generalized pattern of spikes and/or polyspikes and waves). All other tests are normal.
Treatment And Prognosis:
Both medical treatment and counselling are important in the management of juvenile myoclonic epilepsy. Mono-therapy with valproate is the preferred treatment. Some of the newer antiepileptic drugs have been suggested as possible alternatives. Juvenile myoclonic epilepsy has a good prognosis. Lifelong treatment is usually considered necessary in vast majority of patients due to the increased risk of relapse if treatment is discontinued.
Conclusion:
Juvenile myoclonic epilepsy is a common, although under-diagnosed epileptic syndrome. The clinician should study the occurrence of myoclonic jerks and should consider atypical presentations.
Related Concept Videos
Epilepsy ll: Types
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Seizures ll: Types
Seizures l: Introduction
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...


